Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) Other Operating Expenses (2016 - 2023)

Assembly Biosciences has reported Other Operating Expenses over the past 6 years, most recently at -$75.2 million for Q4 2023.

  • Quarterly results put Other Operating Expenses at -$75.2 million for Q4 2023, changed N/A from a year ago — trailing twelve months through Sep 2024 was -$75.2 million (changed N/A YoY), and the annual figure for FY2023 was -$75.2 million, changed.
  • Other Operating Expenses for Q4 2023 was -$75.2 million at Assembly Biosciences, down from $41.6 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for ASMB hit a ceiling of $41.6 million in Q4 2021 and a floor of -$75.2 million in Q4 2023.
  • Median Other Operating Expenses over the past 3 years was $2500.0 (2019), compared with a mean of -$8.4 million.
  • Peak annual rise in Other Operating Expenses hit 104.35% in 2019, while the deepest fall reached 103.15% in 2019.
  • Assembly Biosciences' Other Operating Expenses stood at $4000.0 in 2019, then skyrocketed by 1040850.0% to $41.6 million in 2021, then tumbled by 280.67% to -$75.2 million in 2023.
  • The last three reported values for Other Operating Expenses were -$75.2 million (Q4 2023), $41.6 million (Q4 2021), and $4000.0 (Q2 2019) per Business Quant data.